Araştırma Makalesi
BibTex RIS Kaynak Göster

Evaluation of etiology, clinical and laboratory data of childhood arthritis

Yıl 2019, , 492 - 497, 31.12.2019
https://doi.org/10.18663/tjcl.461632

Öz

Aim: The aim of the present study was to evaluate the etiologies, diagnostic approach, clinical and laboratory data of patients with arthritis in a Turkish tertiary care hospital in children.

Patients and Methods: 306 hospitalized children aged between 7
months-18 years, diagnosed with arthritis were included in the study between
 2008 – 2013. The medical records of patients were reviewed retrospectively.

Results: Of
the patients, 51.6% were female, 48.4% were male. The average age was 118 months.
Arthritis was symmetrical type in 29.4% of patients and asymmetrical type in 70.6%.
The diagnoses of patients were Acute Rheumatic Fever/Poststreptococcal reactive
arthritis (ARF/PSRA) (39.2%), Collagen Tissue Disorders (CTD) (29%), Brucellar
arthritis (13.4%), reactive arthritis (12.5%), septic arthritis (5.2%) and arthritis
secondary to malignancy (0.7%), respectively. Of the patients with CTD; Juvenil
idiopathic arthritis (JIA) was the most common in frequency (66.3%). Patellar
joint involvement was the most common in frequency (62.4%).
The mean ASO levels was significantly higher in
patients with ARF/PSRA group [p=0.000]. Average leucocyte count of ARF/PSRA group
was significantly higher than CTD group [p=0.000]. Average neutrophil
percentage was significantly higher in ARF/PSRA group than brucellar arthritis
group [p=0.000]. The mean duration of diagnosis and therapy was found to be
significantly longer in patients with CTD [p=0.000]. All patients were cured
except
one patient with brucellar arthritis.

Conclusion:









Arthritis can
be a manifestation of multiple disease processes in children. Therefore, the
clinician must consider a broad differential diagnosis. Detail history and physical examination with a clinical follow-up in
addition to useful laboratory testing may help
to establish the cause of arthritis in children.

Kaynakça

  • 1. Tan A, Strauss VY, Protheroe J, Dunn KM. Epidemiology of paediatric presentations with musculoskeletal problems in primary care. BMC Musculoskelet Disord 2018; 19:40.
  • 2. Kimura Y, Southwood TR. Evaluation of the child with joint pain and/or swelling. https://www.uptodate.com. 2018.
  • 3. Cavkaytar O, Düzova A, Tekşam O and et al. Final diagnosis of children and adolescents with musculoskeletal complaints. Minerva Pediatr 2017; 69:50-58.
  • 4. Selmi C, Gershwin ME. Diagnosis and classification of reactive arthritis. Autoimmun Rev 2014; 13: 546-49.
  • 5.Yang YH, Yu HH, Chiang BL. The diagnosis and classification of Henoch-Schönlein purpura: an updated review. Autoimmun Rev 2014; 13: 355-58.
  • 6. Pilkington C, Tjärnlund A, Bottai M and et al; members of the IMCCP International Myositis Classification Criteria Project. Progress report on the development of new classification criteria for adult and juvenile idiopathic inflammatory myopathies. Arthritis Rheumatol 2014; 66: 70.
  • 7.Burke RJ, Chang C. Diagnostic criteria of acute rheumatic fever. Autoimmun Rev 2014; 13: 503-7.
  • 8. Stephenson JL, Shipman AR. The Systemic Lupus International Collaborating Clinics criteria have replaced the American College of Rheumatology guidelines for the diagnosis of systemic lupus erythematosus. Clin Exp Dermatol 2014; 39: 431-32.
  • 9. Riise QR, Handeland KS, Cvancarova M and et al. Incidence and Characteristics of Arthritis in Norwegian Children: A Population-Based Study Pediatrics 2008; 121: 299-306.
  • 10. Cattalini M, Soliani M, Caparello MC and et al. Sex differences in Pediatric Rheumatology. Clin Rev Allergy Immunol 2017.
  • 11. Narin N, Mutlu F, Argun M and et al. Incidence and clinical features of acute rheumatic fever in Kayseri, Central Anatolia, 1998-2011. Cardiol Young. 2015; 25: 745-51.
  • 12. Boyarchuk O, Boytsanyuk S, Hariyan T. Acute rheumatic fever: clinical profile in children in western Ukraine. J Med Life 2017; 10: 122-26.
  • 13. Sato S, Uejima Y, Suganuma E and et al. A retrospective study: Acute rheumatic fever and post-streptococcal reactive arthritis in Japan. Allergol Int 2017; 66: 617-20.
  • 14. Olaosebikan BH, Adelowo OO, Animashaun BA and et al. Spectrum of paediatric rheumatic diseases in Nigeria. Pediatr Rheumatol Online J 2017; 15:7.
  • 15. Aksu K, Dokuyucu O, Ertenli AI and et al. Cost of Familial Mediterranean Fever [FMF] Disease In Turkey. Value Health 2015; 18: 666.
  • 16. Parlak M, Akbayram S, Doğan M and et al. Clinical manifestations and laboratory findings of 496 children with brucellosis in Van, Turkey. Pediatr Int 2015; 57: 586-89.
  • 17. Bosilkovski M, Kirova-Urosevic V, Cekovska Z and et al. Osteoarticular involvement in childhood brucellosis: experience with 133 cases in an endemic region. Pediatr Infect Dis J 2013; 32 :815-19.
  • 18. Yu DT, Van Tubergen A. Reactive arthritis 2018.
  • 19. Di Loreto S, Fabiano C, Nigro G. High prevalence of streptococcal or Epstein-Barr virus infections in children with acute non-septic monoarthritis. New Microbiol 2014; 37:81-86.

Çocukluk çağı artritlerinin etyolojik, klinik ve laboratuar verilerinin değerlendirilmesi

Yıl 2019, , 492 - 497, 31.12.2019
https://doi.org/10.18663/tjcl.461632

Öz

Amaç: Bu çalışmanın
amacı üçüncü basamak olan bir sağlık kuruluşunda artrit tanısıyla takip edilen çocuk
hastaların etyolojisi, tanısal yaklaşımı, klinik ve laboratuvar verilerinin
değerlendirilmesidir.



Hastalar ve
Yöntemler: 2008 - 2013 yılları arasında, 7 ay-18 yaş arasında, hastanede
yatarak tedavi gören 306 artrit tanılı çocuk çalışmaya dahil edildi. Hastaların
tıbbi kayıtları retrospektif olarak incelendi.



Bulgular:
Hastaların % 51,6'sı kız, % 48.4'ü erkekti. Yaş ortalaması 118 ay idi. Hastaların
% 29.4'ünde simetrik, % 70.6'sında asimetrik tip artrit tespit edildi. Hastaların
tanıları sırasıyla Akut Romatizmal Ateş/Poststreptokoksik reaktif artrit (ARA/PSRA)
(% 39.2), Kollajen doku hastalığı (KDH) (% 29), brusella artriti (% 13.4),
reaktif artrit (% 12.5), septik artrit (% 5.2) ve maligniteye bağlı artrit (%
0.7) idi. Kollajen doku hastalığı grubunda jüvenil idyopatik artrit (JİA) en
sık görülen hastalık idi (% 66.3). Patellar eklem tutulumu en sık tutulan
eklemdi (% 62.4). ARA / PSRA grubu olan hastalarda ortalama ASO düzeyleri
yüksek bulundu [p = 0.000]. ARA / PSRA grubunun ortalama lökosit sayısı, KDH
grubundan yüksekti [p = 0.000]. ARA / PSRA grubunda ortalama nötrofil yüzdesi
brusella artriti grubundan daha yüksekti [p = 0.000]. KDH hastalarında ortalama
tanı ve tedavi süresi daha uzun bulundu [p = 0.000]. Brusella artriti tanılı bir
hasta hariç tüm hastalar sekelsiz iyileşti.



Sonuç:



Artrit çocukluk
çağında sistemik hastalık sürecinin bir bulgusu olabilir. Bu nedenle klinisyenin
ayırıcı tanı listesi geniş olmalıdır. Kapsamlı öykü ve fizik muayeneye ek
olarak seçilecek uygun laboratuvar testleriyle birlikte klinik izlem çocukluk
çağında artrit nedenlerini aydınlatmaya yardımcı olabilir.

Kaynakça

  • 1. Tan A, Strauss VY, Protheroe J, Dunn KM. Epidemiology of paediatric presentations with musculoskeletal problems in primary care. BMC Musculoskelet Disord 2018; 19:40.
  • 2. Kimura Y, Southwood TR. Evaluation of the child with joint pain and/or swelling. https://www.uptodate.com. 2018.
  • 3. Cavkaytar O, Düzova A, Tekşam O and et al. Final diagnosis of children and adolescents with musculoskeletal complaints. Minerva Pediatr 2017; 69:50-58.
  • 4. Selmi C, Gershwin ME. Diagnosis and classification of reactive arthritis. Autoimmun Rev 2014; 13: 546-49.
  • 5.Yang YH, Yu HH, Chiang BL. The diagnosis and classification of Henoch-Schönlein purpura: an updated review. Autoimmun Rev 2014; 13: 355-58.
  • 6. Pilkington C, Tjärnlund A, Bottai M and et al; members of the IMCCP International Myositis Classification Criteria Project. Progress report on the development of new classification criteria for adult and juvenile idiopathic inflammatory myopathies. Arthritis Rheumatol 2014; 66: 70.
  • 7.Burke RJ, Chang C. Diagnostic criteria of acute rheumatic fever. Autoimmun Rev 2014; 13: 503-7.
  • 8. Stephenson JL, Shipman AR. The Systemic Lupus International Collaborating Clinics criteria have replaced the American College of Rheumatology guidelines for the diagnosis of systemic lupus erythematosus. Clin Exp Dermatol 2014; 39: 431-32.
  • 9. Riise QR, Handeland KS, Cvancarova M and et al. Incidence and Characteristics of Arthritis in Norwegian Children: A Population-Based Study Pediatrics 2008; 121: 299-306.
  • 10. Cattalini M, Soliani M, Caparello MC and et al. Sex differences in Pediatric Rheumatology. Clin Rev Allergy Immunol 2017.
  • 11. Narin N, Mutlu F, Argun M and et al. Incidence and clinical features of acute rheumatic fever in Kayseri, Central Anatolia, 1998-2011. Cardiol Young. 2015; 25: 745-51.
  • 12. Boyarchuk O, Boytsanyuk S, Hariyan T. Acute rheumatic fever: clinical profile in children in western Ukraine. J Med Life 2017; 10: 122-26.
  • 13. Sato S, Uejima Y, Suganuma E and et al. A retrospective study: Acute rheumatic fever and post-streptococcal reactive arthritis in Japan. Allergol Int 2017; 66: 617-20.
  • 14. Olaosebikan BH, Adelowo OO, Animashaun BA and et al. Spectrum of paediatric rheumatic diseases in Nigeria. Pediatr Rheumatol Online J 2017; 15:7.
  • 15. Aksu K, Dokuyucu O, Ertenli AI and et al. Cost of Familial Mediterranean Fever [FMF] Disease In Turkey. Value Health 2015; 18: 666.
  • 16. Parlak M, Akbayram S, Doğan M and et al. Clinical manifestations and laboratory findings of 496 children with brucellosis in Van, Turkey. Pediatr Int 2015; 57: 586-89.
  • 17. Bosilkovski M, Kirova-Urosevic V, Cekovska Z and et al. Osteoarticular involvement in childhood brucellosis: experience with 133 cases in an endemic region. Pediatr Infect Dis J 2013; 32 :815-19.
  • 18. Yu DT, Van Tubergen A. Reactive arthritis 2018.
  • 19. Di Loreto S, Fabiano C, Nigro G. High prevalence of streptococcal or Epstein-Barr virus infections in children with acute non-septic monoarthritis. New Microbiol 2014; 37:81-86.
Toplam 19 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Özgün Makale
Yazarlar

Özge Dedeoğlu 0000-0002-7492-5255

Eyüp Sarı Bu kişi benim 0000-0003-1190-2483

Saliha Şenel 0000-0002-7734-8721

Can Demir Karacan 0000-0001-5301-8106

Yayımlanma Tarihi 31 Aralık 2019
Yayımlandığı Sayı Yıl 2019

Kaynak Göster

APA Dedeoğlu, Ö., Sarı, E., Şenel, S., Karacan, C. D. (2019). Evaluation of etiology, clinical and laboratory data of childhood arthritis. Turkish Journal of Clinics and Laboratory, 10(4), 492-497. https://doi.org/10.18663/tjcl.461632
AMA Dedeoğlu Ö, Sarı E, Şenel S, Karacan CD. Evaluation of etiology, clinical and laboratory data of childhood arthritis. TJCL. Aralık 2019;10(4):492-497. doi:10.18663/tjcl.461632
Chicago Dedeoğlu, Özge, Eyüp Sarı, Saliha Şenel, ve Can Demir Karacan. “Evaluation of Etiology, Clinical and Laboratory Data of Childhood Arthritis”. Turkish Journal of Clinics and Laboratory 10, sy. 4 (Aralık 2019): 492-97. https://doi.org/10.18663/tjcl.461632.
EndNote Dedeoğlu Ö, Sarı E, Şenel S, Karacan CD (01 Aralık 2019) Evaluation of etiology, clinical and laboratory data of childhood arthritis. Turkish Journal of Clinics and Laboratory 10 4 492–497.
IEEE Ö. Dedeoğlu, E. Sarı, S. Şenel, ve C. D. Karacan, “Evaluation of etiology, clinical and laboratory data of childhood arthritis”, TJCL, c. 10, sy. 4, ss. 492–497, 2019, doi: 10.18663/tjcl.461632.
ISNAD Dedeoğlu, Özge vd. “Evaluation of Etiology, Clinical and Laboratory Data of Childhood Arthritis”. Turkish Journal of Clinics and Laboratory 10/4 (Aralık 2019), 492-497. https://doi.org/10.18663/tjcl.461632.
JAMA Dedeoğlu Ö, Sarı E, Şenel S, Karacan CD. Evaluation of etiology, clinical and laboratory data of childhood arthritis. TJCL. 2019;10:492–497.
MLA Dedeoğlu, Özge vd. “Evaluation of Etiology, Clinical and Laboratory Data of Childhood Arthritis”. Turkish Journal of Clinics and Laboratory, c. 10, sy. 4, 2019, ss. 492-7, doi:10.18663/tjcl.461632.
Vancouver Dedeoğlu Ö, Sarı E, Şenel S, Karacan CD. Evaluation of etiology, clinical and laboratory data of childhood arthritis. TJCL. 2019;10(4):492-7.


e-ISSN: 2149-8296

The content of this site is intended for health care professionals. All the published articles are distributed under the terms of

Creative Commons Attribution Licence,

which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.